ScrutarSign up free

Caris Life Sciences, Inc. (CAI) Earnings

Caris Life Sciences, Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.

Next earnings (estimated)
Around Feb 25, 2027
After market close
Get notified when CAI reports →
Last reported earnings
Nov 4, 2026
From the latest earnings 8-K
Revenue • FY2025
$812.03M
As reported
Diluted EPS • FY2025
-$3.22
As reported

Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from CAI's historical reporting pattern, not a company-confirmed date.

Headline financials

PeriodRevenueNet incomeGross profitDil. EPSFree cash flowOp. marginRev. growth
FY2025$812.03M-$68.09M—-$3.22$66.89M5.6%—

Recent earnings filings

FiledFormAccession
Nov 4, 20268-K (2.02)EDGAR
Aug 5, 20268-K (2.02)EDGAR
May 7, 20268-K (2.02)EDGAR
Feb 26, 20268-K (2.02)EDGAR
Jan 12, 20268-K (2.02)EDGAR
Nov 5, 20258-K (2.02)EDGAR
Aug 12, 20258-K (2.02)EDGAR

Never miss a CAI filing.

Get an email when CAI files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

← Back to CAI overview

Data as of Nov 9, 2026Source: SEC EDGAR.